Register Login
Welcome to the Fritsma Factor

Please join our
hemostasis discussions.

George Fritsma

MS, MLS, Lab Scientist, Educator, Author

George Fritsma is a medical laboratory scientist, educator, and author. George contributed five chapters to Keohane EM, Butina MM, Mirza KM, Walenga JM: Rodak’s Hematology; Clinical Principles and Applications, Seventh Edition, 2025, Elsevier; and is the co-author of Bennett A, Fritsma GA, Ernst DJ: Quick Guide to Blood Collection Edition 2, 2016, Marques MB, Fritsma GA: Quick Guide to Coagulation Testing Edition 3, 2015, and Reddy V, Marques MB, Fritsma GA: Quick Guide to Hematology Testing Edition 2, 2013, along with three additional titles, all published by AACC Press. He is a consultant in the Laboratory Medicine Department of Pathology at the University of Alabama at Birmingham. George is a member of the International Society on Thrombosis and Hemostasis, the International Society for Laboratory Hematology, and the American Society for Clinical Laboratory Science.

read more

Most Recent

World Federation of Hemophilia Requests Your Comment

Thanks to Elaine Benoit, PBI, for this heads-up: The WFH invites healthcare professionals, people with hemophilia, caregivers, patient organizations, researchers, industry representatives, government officials, and other stakeholders to provide feedback on the draft WFH Guidelines for the Management of Hemophilia: Hemostatic Agents and Prophylaxis. WFH needs your feedback to ensure that the guidelines are practical, […]
read more

Managing Immune Thrombotic Thrombocytopenic Purpura

An open-access review on immune TTP management: Dong H, Zheng XL. Guided precision management of iTTP: optimizing treatment, monitoring, and relapse prevention. Expert Rev Hematol. 2026 Nov 15:1-16. doi: 10.1080/17474086.2026.2763858. PMID: 43021537. ABSTRACT Introduction Immune-mediated thrombotic thrombocytopenic purpura (iTTP) is caused by severe deficiency of plasma ADAMTS13 (A Disintegrin And Metalloprotease with Thrombospondin type 1 […]
read more

Anticoagulant Therapy Interruption

An open-access qualitative research article that describes patient experience with anticoagulation interruption:  Tafur A, Jensen S, Marquez A, Greenberg S, Wallach B, Connors J, Levy J, Durante M, Preston A, Douketis J. Navigating the pause-patient experiences with perioperative anticoagulation interruption: a qualitative study. Res Pract Thromb Haemost. 2026 Jul 28;10(5):106890. doi: 10.1016/j.rpth.2026.106890. PMID: 42662610; PMCID: […]
read more

Study: Adverse Effects of DOACs in Pregnancy

Click here for this open-access article describing pregnancy loss and fetal defects in anticoagulation: Dao K, Beck E, Pizzoglio-Billaudaz V, et al. Reproductive safety of direct oral anticoagulants after maternal exposure in early pregnancy: a comparative European Network of Teratology Information Services cohort study. J Thromb Haemost. 2026:S1538-7836(26)00572-6. doi: 10.1016/j.jtha.2026.08.037. PMID: 42744052. Abstract Background: Direct […]
read more

Mobility and VTE

Results of a study linking immobility and VTE: Hoyer EH, Brotman DJ, Young DL, et al. Every step counts: incremental mobility and venous thromboembolism risk among adult general medicine inpatients. J Thromb Haemost. 2026:S1538-7836(26)00566-0. doi: 10.1016/j.jtha.2026.09.006. PMID: 42731731. Available from your local medical library. Abstract Background: Hospital-associated venous thromboembolism (VTE) is a leading but preventable […]
read more

Questions or Comments?